[The role of leukotriene D4 antagonist in allergic rhinitis with steroid resistance]

Lin Chuang Er Bi Yan Hou Ke Za Zhi. 2005 Jun;19(12):557-9.
[Article in Chinese]

Abstract

Objective: To study the effect of using leukotriene D4 antagonist (LTRAs) and inhaled corticosteroid (ICS) to allergic rhinitis (AR), as well as the effect of leukotriene D4 antagonist on allergic rhinitis with steroid resistance.

Method: Several different inhaled corticosteroid were used to deal with allergic rhinitis and assess their effect by scores. The patients with steroid resistance were treated with montelukast sodium 10 mg/day for two weeks.

Result: There is higher rate of steroid resistance among patients with both of kind symptoms of allergic rhinitis and asthma. Montelukast sodium can significantly alleviate the symptom of patients who suffer from allergic rhinitis with steroid resistance (P < 0.05). Cooperative utilization of mometasone furoate and montelukast sodium is more effective to alleviate allergic symptoms.

Conclusion: Leukotriene D4 antagonist can be an adjunct therapy of allergic rhinitis with steroid resistance. Cooperative utilization of leukotriene D4 antagonist and inhaled corticosteroid in allergic rhinitis can be considerable.

MeSH terms

  • Acetates / therapeutic use*
  • Administration, Inhalation
  • Adolescent
  • Adult
  • Aged
  • Child
  • Child, Preschool
  • Cyclopropanes
  • Female
  • Glucocorticoids / administration & dosage
  • Glucocorticoids / therapeutic use
  • Humans
  • Leukotriene Antagonists / therapeutic use*
  • Male
  • Middle Aged
  • Quinolines / therapeutic use*
  • Rhinitis, Allergic, Perennial / drug therapy*
  • Sulfides

Substances

  • Acetates
  • Cyclopropanes
  • Glucocorticoids
  • Leukotriene Antagonists
  • Quinolines
  • Sulfides
  • montelukast